-
C-Ross Explainer - Liquidity risk
15 March 2022C-Ross Phase II imposes requirements for liquidity stress tests and spells out regulatory indicators for potential illiquidity danger
-
Rapid rate rise a primary risk for US life insurers
14 March 2022Federal Reserve due to start raising rates this week
-
AXA IM Alts looks to "re-invent" office assets
14 March 2022An important asset class after two years of remote working, the manager said
-
Talanx reports 11% investment income increase
14 March 2022Due to gains from alternative investments and inflation-linked bonds
-
French central bank governor announces further slow-down of QE programme
14 March 2022But "we won't touch interest rates", he says
-
AIA reveals Chinese investment mix as C-Ross Phase II begins
14 March 2022Group boosted China sovereigns in 2021 at expense of all other debt holdings
-
PIC reports growing investment especially in private debt
11 March 2022While it continues to de-risk the portfolio
-
MAPFRE to halt investments in coal, oil and gas companies
11 March 2022Which are not aligned with 1.5C transition
-
Hannover Re reports €7bn increase in AuM
11 March 2022A result of a strong performance from inflation-linked bonds and alternatives
-
Internal model users' understanding of market and credit risk varies greatly
11 March 2022Which calls for continuous supervisory scrutiny, EIOPA says
Most Read
- UK buy-in volumes could hit £55bn in 2026, LCP says
- Can you measure productive finance?
- Outsourcing RT series: Part IV, The future for outsourcing
- Schroders Greencoat signs MoU with China-based battery-maker for European platform
- Geopolitical hotseat: The same pace of drama can't continue for rest of year, Conning CIO says
- Conning CIO says Fed independence intact as Trump names nominee for Fed chair
- Fubon Life picks Iconiq Strategic Management as VC tech outsourcing partner
- Cathay Life invests $50m in KKR infrastructure fund
- Chart of the Week - How bad Trump needs to be, to make Danish insurers insolvent
- It's still early innings for Alt IM-owned insurers - what's their play?